Fort Collins, Colorado Clinical Trials

A listing of Fort Collins, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.

Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 0 views
  • 23 Jul, 2022
  • +206 other locations
A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant (AURIGA)

The purpose of this study is to evaluate conversion rate to minimal residual disease (MRD) negativity following the addition of daratumumab to lenalidomide relative to lenalidomide alone, when administered as maintenance treatment to anti-cluster of differentiation 38 (CD38) treatment naive participants with newly diagnosed multiple myeloma who are MRD positive …

bone marrow procedure
progressive disease
daratumumab
lenalidomide
cell transplantation
University of Colorado Health
 (7.5 away) Contact site
  • 92 views
  • 23 Jul, 2022
  • +65 other locations
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

This phase II trial studies whether atezolizumab in combination with talazoparib works better than atezolizumab alone as maintenance therapy for patients with SLFN11-positive extensive-stage small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability …

HIV Infection
metastasis
tumor cells
neutrophil count
cancer
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 0 views
  • 25 Jul, 2022
  • +401 other locations
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

This phase III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells …

Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 0 views
  • 27 Jul, 2022
  • +66 other locations
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread outside of the lung or to other parts of …

metastasis
tumor cells
neutrophil count
cancer
etoposide
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 6 views
  • 28 Jul, 2022
  • +143 other locations
Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

This is a multicenter, longitudinal, single-arm, open-label study to describe the change from baseline in cognitive processing speed, measured by the SDMT, in subjects with RMS treated with ozanimod HCl 1 mg at 3 years. All subjects will receive orally administered ozanimod HCl 1 mg. The primary efficacy endpoint is …

relapsing multiple sclerosis
Advanced Neurosciences Research, LLC
 (7.5 away) Contact site
  • 279 views
  • 29 Jul, 2022
  • +58 other locations
Targeting ER Stress in Vascular Dysfunction

Aging and obesity are both risk factors for cardiovascular disease (CVD). One process that links both of these conditions to CVD is vascular dysfunction. Data from animal studies indicate that endoplasmic reticulum (ER) stress may play an important role in the development of endothelial dysfunction in aging and obesity. Therefore, …

Accepts healthy volunteers
Colorado State University
 (0.0 away) Contact site
  • 11 views
  • 29 Jul, 2022
  • 1 location
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

This phase II trial compares cabozantinib alone and the combination of cabozantinib and nivolumab to standard chemotherapy in the treatment of patients with non-squamous non-small cell lung cancer (NSCLC). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal …

kinase inhibitor
pd-l1
HIV Infection
metastasis
tumor cells
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 25 views
  • 08 Aug, 2022
  • +438 other locations
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as gemcitabine, cisplatin, fluorouracil and mitomycin-C, work in different …

bcg vaccine
monoclonal antibody therapy
HIV Infection
bladder tumor
tumor cells
Cancer Care and Hematology-Fort Collins
 (7.5 away) Contact site
  • 42 views
  • 09 Aug, 2022
  • +183 other locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

This trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

stereotactic body radiation therapy
neutrophil count
atezolizumab
kidney function test
ct scan
Cancer Care and Hematology-Fort Collins
 (8.1 away) Contact site
  • 0 views
  • 09 Aug, 2022
  • +156 other locations